Back to search

Article

Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue

2003-01-15

Abstract excerpt

Current therapeutic strategies for genetic skin disorders rely on the complex process of grafting genetically engineered tissue to recipient wound beds. Because fibroblasts synthesize and secrete extracellular matrix, we explored their utility in recessive dystrophic epidermolysis bullosa (RDEB), a blistering disease due to defective extracellular type VII collagen. Intradermal injection of RDEB fibroblasts overex...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cee61de1-424e-5db6-9d45-ce284306403d
DOI
10.1172/jci200317193
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissueDOI 10.1172/jci200317193
Select a neighboring publication to make it the new centre.